NEXT Pharma is proud to introduce Dapanext (Dapagliflozin) and Dapanext M (Dapagliflozin + Metformin), two innovative medications set to transform the landscape of Type 2 Diabetes management. These new offerings underscore our dedication to providing advanced therapeutic solutions that go beyond simple blood sugar control, addressing the broader health needs of patients.

This launch signifies NEXT Pharma’s ongoing commitment to innovation, providing healthcare professionals with advanced tools to improve patient outcomes and enhance the quality of life for individuals living with Type 2 Diabetes and its associated complications.